References
- Amit AK, Vandana BP. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS Pharm Sci Tech 2008; 9: 191–6
- Caliph SM, Charman WN, Porter CJH. Effect of short-, medium-, and longchain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymphcannulated and non-cannulated rats. J Pharm Sci 2000; 89: 1073–84
- Chu MQ, Gu HC. The study on the preparation of tanshonones propoliposomes by the spray drying method. Chin Pharm J 2002; 37: 32–5
- de Smidt PC, Campanero MA, Troconiz IF. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: Contribution of emulsification versus digestibility. Int J Pharm 2004; 270: 109–18
- Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: Design, optimization and evaluation. Eur J Pharm Sci 2008; 35: 183–92
- Dooley M, Plosker G. Zaleplon: A review of its use in the treatment of insomnia. Drugs 2000; 60: 413–45
- Drover DR. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives zaleplon, zolpidem and zopiclone. Clin Pharmacokinet 2004; 43: 227–38
- El-Shabouri MH. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm 2002; 249: 101–8
- Gao F, Zhang Z, Bu H, Huang Y, Gao Z, Shen J, Zhao C, Li Y. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism. Int J Pharm 2011; 149: 168–74
- Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB. Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 2011; in press, doi: 10.1016/j.apt.2011.06.005
- Hiremath PS, Soppimath KS, Betagiri GV. Proliposomes of exemestane for improved oral delivery: Formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm 2009; 380: 96–104
- Holm R, Porter CJ, Edwards GA, Mullertz A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in selfmicroemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003; 20: 91–7
- Janga KY, Jukanti R, Velpula A, Sunkavalli S, Bandari S, Kandadi P, Veerareddy PR. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge. Eur J Pharm Biopharm 2012; 80: 347–57
- Kapsi SG, Ayres JW. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int J Pharm 2001; 229: 193–203
- Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic selfemulsifying formulations of halofantrine. Int J Pharm 1998; 167: 155–64
- Kommura TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm 2001; 212: 233–46
- Li H, An JH, Park JS, Han K. Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor. Arch Pharm Res 2005; 28: 988–94
- LianDong H, Xing T, FuDe C. Solid lipid nano-particles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004; 9: 1527–35
- Lipinski CA. Poor aqueous solubility–an industry wide problem in drug discovery. Am Pharm Rev 2002; 5: 82–5
- Malladi M, Jukanti R, Nair N, Wagh S, Padakanti H, Mateti A. Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets. Acta Pharm 2010; 60: 267–80
- Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 2005; 107: 215–28
- Mou D, Chen H, Du D, Mao C, Wan J, Xu H, Yang X. Hydrogel- thickened nanoemulsion system for topical delivery of lipophilic drugs. Int J Pharm 2008; 353: 270–6
- Nassar T, Rom A, Nyska A, Benita S. Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug. J Control Release 2009; 33: 77–84
- Pouton CW. Effects of inclusion of a model drug on the performance of selfemulsifying formulations. J Pharm Pharmacol 1985; 37: 1–11
- Prego C, Fabre M, Torres D, Alonso MJ. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 2006; 23: 549–56
- Robert GS. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004; 21: 201–30
- Rogers TL, Hu J, Yu Z, Johnston KP, Williams III RO. A novel particle engineering technology: Spray freezing into liquid. Int J Pharm 2002; 242: 93–100
- Staniforth J. Powder flow. Pharmaceutics: The science of dosage form design,2nd, M Aulton. Churchill Livingstone, Longman group, Edinburgh 2002; 197–210
- Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Solid dispersion particles of amorphous indomethacin with fine porous silica particle by spray-drying method. Int J Pharm 2005; 293: 155–64
- Tayel SA, Soliman II, Louis D. Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique. Eur J Pharm Biopharm 2008; 69: 342–7
- Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery. Pharmazie 2006; 61: 106–11
- Valleri M, Mura P, Maeshrelli F, Cirri M, Ballerini R. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm 2004; 30: 525–34
- Veiga F, Fernandes C, Maincent P. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems. Drug Dev Ind Pharm 2001; 27: 523–32
- Waghmare A, Pore Y, Kuchekar B. Development and characterization of zaleplon solid dispersion systems: A technical note. AAPS Pharm Sci Tech 2008; 9: 536–43
- Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, Shim CK, Kim DD. Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluation. J Control Release 2009; 140: 86–94
- Yosra SRE, Magda AE, Ossama YA. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm 2009; 380: 133–41
- Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Azarmi Y, Islambolchilar Z, Barzegara S, Barzegar-Jalali M. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J Pharm Pharmaceut Sci 2007; 10: 368–79
- Zhang Z, Bu H, Gao Z, Huang Y, Gao F, Li Y. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase orla bioavailability in rats. Int J Pharm 2010; 394: 147–53
- Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery systems of oridonin. Int J Pharm 2008; 355: 269–76
- Zhang B, Zhang Z, Tian Y, Xua F, Chen Y. High-performance liquid chromatography–atmospheric pressure chemical ionisation-mass spectrometry determination of zaleplon in human plasma. J Pharm Biomed Anal 2006; 40: 707–14
- Zheng JY, Fulu MY. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion. Int J Pharm 2006; 307: 209–15
- Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. Quality by design: Understanding the product variability of a selfnanoemulsified drug delivery system of cyclosporine A. J Pharm Sci 2007; 96: 2409–23